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SUMMARY: a-(l-+2)-&-Fucosidase, B-D-galactosidase and galactose oxidase are 
sterically hindered by certain typ& of branching in the oligosaccharide 
ChdllS. 1) 8-g-Galactosidase will not cleave galactose when the penultimate 
sugar carries a sialic acid residue as in I. 2) Gatactose Otidase will not 
oxidize the galactose residue in trisaccharide I but will in II. Moreover, 
neither galactose nor i-acetylgalactosamine, glycosidically bound as in III, 
is susceptible to oxidation with galactose oxidase until the a-(1+3) linkage 
between them is cleaved by a-g-acetylgalactosaminidase. 3) a-(1+2)-L-Fuco- 
siduae action is inhibited by a-(l-+3)-&acetylgalactosaminyl or galaTtosy1 
residue, as in III and IV. Removal of the terminal sugars makes the fucosyl 
residue susceptible to fucosidase action. 




III GalNAc(a1+3)Ga1(81+3)GalNAcol IV Gal(a1+3)Ga1(81+3)GlcNA~ - 
t a(l,Z) 
FUC iuc 
INTRODUCTION: We had previously presented evidence, derived from periodate 
oxidation studies (l), for the structures of the oligosaccharides from A+, 
+ H 
and A-H-hog submaxillary glycoproteins (2). Further studies by NMR spectro- 
scopy and permethylation analysis gave results that did not substantiate 
* To whom correspondence should be addressed 
§ Abbreviations used: A+ PSM, H+ PSM, and A-R- PSM from A and Ii active 
and inactive porcine submaxillary glycoproteins; OSM, ovine submaxillary 
mucin; B+ oligo alditols for the mixture of oligosaccharide alditols isolated 
from B-acti‘ve ovarian cyst fluid; Fuc, L-fucose; Gal, g-galactose; GalNAc, 
IJ-acetyl-pgalactosamine; 
E-glycolyTneuraminic acid; 
GalNAcol, x-a?etyl-D-galactosaminitol; NeuNGl, 
PNP-Gal, R-nitroph;nyl-$-galactoside; PNP-GalNAc, 
p-nitrophenyl-a-acetyl-D-galactosaminide; u = enzyme unit, defined as pmol of 
sugar released per hour: incubated at 37O under optimal conditions with the 
appropriate substrate as indicated in Methods. 
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some of these findings (3). The disagreement revolved around the attachment 
of NeuNGl to Gal or GalNAc. 
One approach contemplated for the resolution of the problem was by the use 
of enzymes such as 6-galactosidase and galactose oxidase. If the galactose 
is terminal and unsubstituted by NeuNGl, it should be susceptible to both 
enzymes. Conversely, resistance to the action of either enzyme would suggest 
substitution. As it turned out, neither statement was correct since an ad- 
ditional factor, that of ateric hindrance, was involved. This became evi- 
dent with the establishment of the structures by NMR and methylation 
studies (3). 
We studied this steric hindrance in greater detail in view of the presence 
of these sugars in many biologically important compounds. 
MATERIALS AND METHODS: Hog submaxillary glycoproteina with A or H reacti- 
vity, A* PSM and H+ PSM, and OSM were prepared as previously described (4). 
The purified oligoaaccharide alditols used in this investigation were ob- 
tained from hog subamxillary glycoproteins by &elimination, alkaline cleav- 
age in the presence of borohydride (1,5,6). The unseparated mixture of 
oligosaccharide alditols of B-active ovarian cyst fluid were also obtained 
by alkaline B-elimination cleavage of a phenol-insoluble fraction (7) of 
lyophiliaed B-active ovarian cyst, a gift from Dr. W.M. Watkins. The syn- 
thetic PNP-glycoaides, PNP-B-Gal and PNP-a-GalNAc, were obtained from Roch- 
Light Laboratories Ltd. and Calbiochem, respectively. Synthetic di- and tri- 
saccharides of established structures (8), with blood group A and B activi- 
ties, were obtained as gifts through the courtesy of Dr. D.A. Baker, 
Chembiomed Ltd. 
The following enzymes were used in these studies: 8-galactosidase (3.2.1.23) 
from bovine testes (9) was a gift from Dr. G.W. Jourdian. a-(1+2)-L-Pucoai- 
dase purified from Rwninococcus (10) was a gift from Dr. L.C. Hoski&, This 
material also contained a-galactosidase activity. Yet another preparation 
of a-&-fucoaidase (3.2.1.51), a gift from Dr. G.W. Jourdian, was a contami- 
nant Nf partially purified S-galactoaidase from bovine testes. a-E-Acetyl- 
galactosaminidase (3.2.1.49) was isolated from Cl. perfringens (10. Siali- 
dase (3.2.1.18), which requires Ca*, was prepared from vibrio cholerae (12). 
a-Galactosidase (3.2.1.22) was prepared from Cl. sporogenes (13). Galactose 
Oxidase (1.1.3.9) was contained in the Galactostat reagent, a commercial 
preparation from Worthington. 
Buffers were used in these experiments: buffer A, 0.1 M sodium acetate, 
pH 4.5, and buffer B, 0.1 M sodium citrate-phosphate, pH 6.0. 
Free GalNAc was measured by a modification (14) of the Morgan-Elson reaction 
(15). Free Gal was determined with galactose dehydrogenaae (1.1.1.120, 
Boehringer-Mannheim) (16). The oxidation of Gal, GalNAc or their derivatives 
was followed by the Galactostat reagent (Worthington). Total aialic acid was 
assayed by a modification of the Svennerholm resorcinol procedure (17) with 
1-butanol replacing iaoamyl alcohol for the development of color (18); and 
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free sialic acid by the thiobarbituric acid procedure (19). Total fucose was 
determined after a 10 min heating period (20), while fucose dehydrogenase 
(1.1.1.122, Sigma) was used to determine the amount of free fucose (16). The 
activities of g-galactosidase, a-fucosidase, and a-E-atetylgalactosaminidase 
were determined by the action of these enzymes on their respective PNP-sub- 
strates using the procedure of McGuire et al (22) for the measurement of free -- 
PNP. B-Active ovarian cyst alditols were used to determine the activity of 
the a-galactosidase from Ihmrin~cocous and the a-galactosidase from CZ. 
sporogenes; OSM for sialidase; and Gal for galactose oxidase. 
RESULTS AND DISCUSSION: Action of g-Galactosidase on Acidic Oligosaccharide 
Alditols from A+, I@ and A-H- Glycoproteins. The acidic trisaccharide aldi- 
tols released from each of the three phenotype glycoproteins (2) A+,I@and AH-, 
gave similar results, Table 1. The release of NeuNGl from the GalNAcol is 
necessary before the release of Gal by g-galactosidase can occur. With the 
acidic tetrasaccharide alditols, Table 2, the release of both fucose and 
NeuNGl by their respective enzymes is required before the action of the 
S-galactosidase can occur. 
Action of a-(1+2)-L-Fucosidase on Various Substrates. A re-examination of 
the action of o-fucosidase on intact glycoproteins (21) was undertaken to 
establish the characteristics of steric hindrance associated with fucosidase. 
It is readily apparent, Table 3, that all of the fucose in El+ PSM glyco- 
protein was susceptible to the action of a-fucosidase (21). In contrast, 
only 22% of the total fucose present in the A+ PSM glycoprotein was sus- 
ceptible to the action of a-fucosidase (Table 3). This compares well with 
results previously presented (21). The addition of either sialidase, 
f+galactosidase, or more a-fucosidase to individual 600 pl aliquots of the 
original incubation mixture did not increase the amount of fucose released. 
However, when _ a-N-acetylgalactosaminidase was added to the incubation mix- 
ture containing fucosidase, almost all the fucose was released within 16 
additional hrs. The results indicate that the terminal non-reducing GalNAc 
is involved in the inability of a-fucosidase to hydrolyze all the fucose from 
the A+ PSM glycoprotein. This was further confirmed by the results obtained 
with the pure isolated acidic pentasaccharide alditol (6) as substrate. 
Again, only with the addition of a-E-acetylgalactosaminidase was the fucose 
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Table I 





% Sugar Releaoed 
Source of Sialidase (1.2~) f3-Galactosidase (0.4~) B-Galactosidase (0.4~) 
Trisaccbaride Sialidase (1.2u) 
0.125 umol NeuNGl Gal NauNGl Gal NeuNGl Gal 
A+ a5 0 0 0 a5 69 
H+ 78 0 0 0 64 66 
A-H- 64 0 0 0 56 51 
Incubations for 16 hr at 37O in 200 ul of buffer A containing 1OmM CaC12 
almost completely released within an additional 16 hrs. 
A parallel series of experiments was performed on B-active ovarian cyst 
alditols. During the initial incubation of the substrate with fucosidase, 
22% of the total fucose was released (Table 3). This most likely resulted 
from the release of fucose from the "biosynthetically incomplete" oligo- 
saccharides which did not contain terminal non-reducing a-galactosyl resi- 
dues - results comparable to those obtained after treatment of A+ PSM with 
a-fucosidase (21). After 48 hrs, a-galactosidase (0.3 u) was added, result- 
ing in the release of an additional 18% of the fucose. 
These observations were further confirmed by the action of a-(1+2)-L- = 
fucosidase on chemically synthesized oligosaccharides of the A and B blood 
group type (Table 4). F'ucose was released by a-fucosidase only after the 
terminal a-GalNAc or a-Gal, blood group A and B determinants, were removed 
by the respective exoglycosidase. 
Action of Galactose Oxidase on Various Oligosaccharides. The results, 
Table 5, illustrate that the cleavage of NeuNGl was again necessary before 
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Table 3 
Action of a-&cosidnse Alone on Various Substrates and vith Subscqumt Additives 
% of Total Bound Fucose Released from Substrate 
Fucosidase alone for 24 hrs. 
ACidiC B-Active 
H+ PSH A+ PSH 
Pentasacchride Ovarian cyst 
Alditol* Aldltols 
2.3 urn01 2.5 umol 3.0 umol 
97 21 0 22 
Plus 
Folloving edzves for further 16 hrs. 
o-ficosidase 1.8u 98 21 0 hQ 
Sialidase 6.0~ 98 21 0 ND 
a-Galnctosidase (48 hr) 0.3u ND ND ND 40 
B-Calactosidase 0.9U 98 21 0 ND 
a-E-Acetylgalactosainidase 0.7~ 98 97 97 ND 
More substrate ND ND 0 ND 
The 24 hr. incubation with fuc'ase (1.8~) in buffer B(5 ml) was also folloved by subsequent 
treatment of 600 ul aliquots of incubation mixture with enzymes as indicated below. Their 




ND, Not Determined 
disaccharide of the antifreeze glycoprotein (23). However, unlike the 
action of B-galactosidase, the presence of fucose bound to the Gal did not 
significantly affect the ability of galactose oxidase to oxidize the Gal 
residue in the tetrasaccharide, as had been observed after NeuNGl had been 
previously cleaved by sialidase. 
Next, the effect of galactose oxidase on the oxidation of a GalNAc residue 
at the non-reducing end of the tetrasaccharide, compound III, was examined. 
No oxidation had occurred even after 24 hrs. However, the addition of 
a-IJ-acetylgalactosaminidase to hydrolyze the terminal GalNAc resulted after 
a further 42 hrs in 98% oxidation of both the free GalNAc and the now ex- 
posed terminal Gal. Thus, the presence of GalNAc at the non-reducing end 
of the oligosaccharide chain prevents the oxidation of both the terminal 
GalNAc and penultimate Gal residues. In like manner, there was negligible 
-idaMon of B cyst alditols on treatment with galactose oxidase. Pre- 
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Table 4 
Enzymatic Cleavage of Synthetic Oligosaccharidee 
X Sugar Released 
a-I+acetylgalactosaminidase a-Fucosidaee a-Fucosidase and 
Alone Alone a-E-acetylgalactoaainidaee 
Substrate GalNAc PUC GalNAc Fuc GalNAc FUC - -- - 




2. GalNAc(al+3)Gal S+R 100 
a-Galactosidase 
Alone 
Substrate Gal - 




ND 0 ND 100 
a-Fucosidase a-Fucosidase and 
Alone a-Galactosidaoe 
FUC Gal Fuc Gal - -- - 




4. Gal(al+3)Gal S+R 100 ND 0 ND 100 ND 
ND, Not Determined 
treatment of the mixture of alditols with a-galactosidase resulted in 100X 
oxidation of galactose released. 
Exoglycosidases have been recommended by a number of authors as valuable 
tools for structural studies (24,25). Previous reports of steric hindrance 
in the action of glycooidases involved inhibition of the action of sialidase 
(26-28) end of aanosidase (29). The studies outlined here indicate that 
ateric hindrance is more widespread. Indeed, the inability to oxidize 
GalNAc a(1+3), the blood group A determinant, and Gal a(1+3), the B deter- 
minant , substantiates our previously unpublished observation that galactose 
oxidase has no effect on the A and B blood group activities (see also 30,31). 
These findings emphasize the need for greater caution in the interpretation 
of results obtained in structural investigations and in studies of biological 
effects of exoglycosidases and galactose oxidase on soluble glycoconjugates 
and cell surfaces. Our findings can be sumarized as follows: 
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Susceptibility to Enzyme 
a-Fuco- B-Galacto- Galactose 
sidase sidase Oxidase 
No No No 
Yes No Yes 
A+B'H' No No No 
A-B+H- No No No 
Table 5 
Qxidation of Galactose by l&lactose Gxidase 
in - 
Acidic Trisaccharide Acidic Tetrasaccharide 
NeuNGl NeuNGl 






Galactose Oxidase Galactose Oxidase Galactose Oxidase 
Alone Sialidase (3~) Sialidase (3~) 
Fuc'ase (1.811) 
Galactose 100 ND ND 
GalNAc 100 ND ND 
GemActito1 ND ND 





0 47 ND 
A-H- O 47 ND 
Acidic Tetra-A+ 0.2 umol 0 40 47 
H+ 0 31 45 
A-H- O 34 47 
ND, Not Determined 
Two ml of Galactostat reagent in a total volume of 3 ml and containing 3 mM CaC12. 
The amount of Gal or GalNAc oxidized vas determined after 16 hr at 37". 
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